Big Pharma’s Monopoly On Ozempic Threatens Access To Diabetes Drug In Communities Of Color Small pharmacies find difficulty in prescribing the drug due to Big Pharma restrictions on the industry. Zenger · Jul 11, 2024
Big Pharma slowed vaccine development A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests Salon · Oct 5, 2023
Draft patent amendment rules undermine pre-grant opposition Draft patent rules threaten pre-grant opposition, a key public health safeguard. Big pharma seeks to remove essential safeguards from India’s patent laws, creating needless hurdles in pre-grant opposition. Draft rules introduce variable fees, power to determine maintainability of representation by individuals/groups. This threatens access to quality-assured, affordable generics & extends… The Hindu · Sep 23, 2023
Amy Klobuchar on Biden's biggest win Minnesota senator and anti-monopoly crusader explains how fixing Medicare's drug problem will help everybody Salon · Sep 23, 2023
With a pharmacare bill on the horizon, Big Pharma’s attack on single-payer drug coverage for Canadians needs a fact check Health Minister Mark Holland announced in August that the federal government intends to introduce pharmacare legislation in the fall. Now the battle lines are being drawn. The Conversation · Sep 11, 2023
South Africa ‘held to ransom’ by big pharma, overcharged for COVID vaccines J&J, Pfizer charged South Africa between 15 and 33 percent more for COVID vaccine doses, contracts reveal. Al Jazeera · Sep 6, 2023
Big Pharma’s playbook for expensive meds Here are just a few of the many examples of drug pricing practices that have driven consumers to demand change Salon · Aug 20, 2023
Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma The Independent UK · Jul 19, 2023
Scam science: How to outsmart the con Authors of "Nobody's Fool" say "There's an unending arms race of people coming up with new ways to try to scam us" Salon · Jul 11, 2023
‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest The Guardian - UK · Jul 8, 2023
Michael Hiltzik: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees. Los Angeles Times · Jun 15, 2023
Naheulbeuk's Dungeon Master brings Two Point Hospital's HR management to Dungeon Keeper Big Sorcery is the new Big Pharma, but the hours are murder. PC Gamer · Jun 11, 2023
Merck sues to block lower Medicare costs The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments Salon · Jun 8, 2023
Did Fox Really Fire Tucker Carlson for Crossing the 'Red Line' of Criticizing Big Pharma, as RFK Jr. Claims? If so, the network failed to enforce the supposed rule before and after cancelling its top-rated host. Reason · May 17, 2023
Businessweek · May 9, 2023 AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma Artificial intelligence can shave years off the development process, and companies like Japan’s Takeda are making large investments.
Chicago Sun-Times · Apr 7, 2023 Experts warn new weight loss medications carry long-term concerns Some doctors, psychologists and eating disorder experts worry these new medications, originally developed to treat diabetes, could become a problem long-term.
Fortune · Mar 28, 2023 Pfizer's chief corporate affairs officer remembers the moment she figured out how to 'break through' to skeptical consumers during COVID Sally Susman is the author of "Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World."
WEKU · Mar 19, 2023 Opioids are devastating Cherokee families. The tribe has a $100 million plan to heal The fentanyl crisis is hitting young people hard, and the highest death rates are in Native American communities. The Cherokee Nation is working to help young families recover.
Tribune News Service · Mar 14, 2023 Why does insulin cost so much? Big Pharma isn’t the only player driving prices Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma.
Sports Illustrated · Jan 25, 2023 What on Earth Is Aaron Rodgers Talking About? The Packers quarterback gets asked about trade rumors, calls out woke culture, Big Pharma.
Tribune News Service · Jul 19, 2022 As Big Pharma loses interest in new antibiotics, infections are only growing stronger Forget COVID-19, monkeypox and other viruses for the moment and consider another threat troubling infectious disease specialists: common urinary tract infections, or UTIs, that lead to emergency room visits and even hospitalizations because of the failure of oral antibiotics.
360info · Jul 13, 2022 China’s Big Pharma bet could change the IP game China’s muscling into the pharmaceutical industry, helping Big Pharma bite back against generics. But its global ambitions might turn the industry upside down.
Benzinga · Jun 9, 2022 Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study Zelira Therapeutics (OTC: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is about to begin a first-ever clinical trial of its own proprietary pain formula for the treatment of diabetic nerve pain against an as-y
Benzinga · Apr 25, 2022 Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami Beach for a full day of networking and education.
Benzinga · Apr 25, 2022 Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran Terran Biosciences is slowly but surely finding its place in the psychedelics industry.